Abstract:Objective: Noninvasive detection of molecular status of astrocytoma is of great clinical significance for predicting therapeutic response and prognosis. We aimed to evaluate whether morphological MRI (mMRI), SWI, DWI, and DSC-PWI could predict Ki-67 labeling index (LI), ATRX mutation, and MGMT promoter methylation status in IDH mutant (IDH-mut) astrocytoma. Methods: We retrospectively analyzed mMRI, SWI, DWI, and DSC-PWI in 136 patients with IDH-mut astrocytoma.The features of mMRI and intratumoral susceptibility signals (ITSS) were compared using Fisher exact test or chi-square tests. Wilcoxon rank sum test was used to compare the minimum ADC (ADCmin), and minimum relative ADC (rADCmin) of IDH-mut astrocytoma in different molecular markers status. Mann-Whitney U test was used to compare the rCBVmax of IDH-mut astrocytoma with different molecular markers status. Receiver operating characteristic curves was performed to evaluate their diagnostic performances. Results: ITSS, ADCmin, rADCmin, and rCBVmax were significantly different between high and low Ki-67 LI groups. ITSS, ADCmin, and rADCmin were significantly different between ATRX mutant and wild-type groups. Necrosis, edema, enhancement, and margin pattern were significantly different between low and high Ki-67 LI groups. Peritumoral edema was significantly different between ATRX mutant and wild-type groups. Grade 3 IDH-mut astrocytoma with unmethylated MGMT promoter was more likely to show enhancement compared to the methylated group. Conclusions: mMRI, SWI, DWI, and DSC-PWI were shown to have the potential to predict Ki-67 LI and ATRX mutation status in IDH-mut astrocytoma. A combination of mMRI and SWI may improve diagnostic performance for predicting Ki-67 LI and ATRX mutation status. Clinical relevance statement: Conventional MRI and functional MRI (SWI, DWI, and DSC-PWI) can predict Ki-67 expression and ATRX mutation status of IDH mutant astrocytoma, which may help clinicians determine personalized treatment plans and predict patient outcomes. Key points: • A combination of multimodal MRI may improve the diagnostic performance to predict Ki-67 LI and ATRX mutation status. • Compared with IDH-mutant astrocytoma with low Ki-67 LI, IDH-mutant astrocytoma with high Ki-67 LI was more likely to show necrosis, edema, enhancement, poorly defined margin, higher ITSS levels, lower ADC, and higher rCBV. • ATRX wild-type IDH-mutant astrocytoma was more likely to show edema, higher ITSS levels, and lower ADC compared to ATRX mutant IDH-mutant astrocytoma.

Relationship Between Pathological Grade, DNA Content and MRI- Appearance in Brain Astrocytic Tumors

Predicting Tumor Recurrence Of Astrocytoma By Ki-67 And Proton Magnetic Resonance Spectra

A correlation study on magnetic resonance imaging features and nuclear DNA contents in meningiomas

Brain Astrocytoma：3T MRI 3D Multivoxel 1H-MRS in Preoperative Grading and Pathological Findings

Application of MRI score in diagnosis of astrocytic tumors

The Correlation Between Fractional Anisotropy Value and Tumor Microarchitecture in Astrocytomas with Different Grade

Diffusion Kurtosis Imaging Reflects Glial Fibrillary Acidic Protein (GFAP), Topo IIα, and O⁶-Methylguanine-DNA Methyltransferase (MGMT) Expression in Astrocytomas.

The Relationship Between the Expression of Tumor Matrix-Metalloproteinase and the Characteristics of Magnetic Resonance Imaging of Human Gliomas

Microvascular Permeability of Brain Astrocytoma with Contrast-Enhanced Magnetic Resonance Imaging: Correlation Analysis with Histopathologic Grade.

The role of apparent diffusion coefficient in the grading of adult isocitrate dehydrogenase-mutant astrocytomas: relationship with the Ki-67 proliferation index

Correlative study between peritumoral edema on MRI and P53 protein in supratentorial astrocytic gliomas

Correlation Between MRI Features and Tumor Risk Grade in Gastrointestinal Stromal Tumors

Oligodendroglial Tumors:The Correlation between Tumor Grades and Tumor MRI Enhancement

The Level of Enhancement on Routine MRI: the Correlations with Angiogenesis in Astrocytomas

Study of 1H-Magnetic Resonance Spectroscopy in the Peritumoral Edema of Astrocytomas in Brain

Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI

Correlation of DTI parameters in the value of diagnosis and the expression of MMP-9, VEGF & uPA in brain glioma

Comparative observation on MRI features of intramedullary ependymoma and astrocytoma

Advances in Gliomas Grading and Biomarker Detection Based on MRI Analysis

Relationship Between Matrix Metalloproteinase-9 Expression and MRI Characteristics of Glioma

Association Between Histopathology and Magnetic Resonance Imaging Texture in Grading Gliomas Based on Intraoperative Magnetic Resonance Navigated Stereotactic Biopsy